Drug Research
$2mn In The US, Gene Therapies Might Become The Standard
In recent years, the high cost of gene therapies has emerged as a major barrier to the development of personalised medicines. Most notably, bluebird...
Press Releases
medmix Drug Delivery (Haselmeier™) and AARDEX® Group Join Forces to Improve Self-Administration of Injectable Drugs in Clinical Trials
medmix Drug Delivery (Haselmeier) and AARDEX Group announced a collaboration, combining Haselmeier´s D-Flex™ Logbook with AARDEX Group’s Medication Adherence software and hardware ecosystem.
Clinical...
News
U.S. Cancer Medicine Pricing Increases 53% In Five Years
According to new research by Katie Porter, U.S. Democratic Representative and a consumer bankruptcy law professor vying for re-election in California, the cost of...
Drug Research
The Reauthorization of The FDA User Fee Comes Into Effect
As anticipated, Congress swiftly reauthorized four important user fee programmes as part of a bill that was essential to passing in order to continue...
Clinical Trials
Cancer Clinical Trials Begin On New Platform In Melbourne
By comparing tumour samples taken before and after treatment, a new clinical trial platform called Brain-POP (brain perioperative) will allow doctors to precisely see...
News
UK R&D Worldwide Spending Share £62bn Short, Data Shows
According to a recent data study by the Institute for Public Policy Research, the UK's share of worldwide research and development (R&D) spending has...
Drug Research
Gene Therapy Transactions Give Wall Street Cautious Optimism
Gene therapy remains a topic of fascination to biopharmaceutical dealmakers despite safety worries and opposition from drug regulators, as seen by a recent flurry...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read